Abstract
To construct a successful treatment model for heroin addiction, it is important to define factors that contribute to relapse. In this translational ambidirectional cohort study, we evaluated 2 groups of heroin addicts that underwent the same therapeutic procedures with different outcomes (133 abstainers and 56 relapsers). The study found a new variable, “relapse marker”, defined by the synergy of the following factors: (a) non-use of tramadol before treatment (p < 0.0005), (b) absence of sense of loss of control over behaviour as a motive for treatment initiation (p = 0.048), (c) use of benzodiazepines in recovery (p < 0.0005), (d) substituting heroin addiction with gambling (p < 0.009), e) younger age (p = 0.012), and (f) explicit parental demand as a treatment motive (p = 0.040). This study reports a mathematical model that predicts relapse and inability to sustain stable abstinence as an outcome of heroin addiction treatment.
Similar content being viewed by others
References
Adinoff, B. (2004). Neurobiological processes in drug reward and addiction. Harvard Review of Psychiatry, 12(6), 305–320. doi:10.1080/10673220490910844.
Allen, T. J., Moeller, F. G., Rhoades, H. M., & Cherek, D. R. (1998). Impulsivity and history of drug dependence. Drug and Alcohol Dependence, 50(2), 137–145.
Best, D. W., Ghufran, S., Day, E., Ray, R., & Loaring, J. (2008). Breaking the habit: a retrospective analysis of desistance factors among formerly problematic heroin users. Drug and Alcohol Review, 27(6), 619–624.
Boyle, K., Polinksy, J. L., & Hser, Y. I. (2000). Resistance to drug abuse treatment: a comparison of drug users who accept or decline treatment referral assessment. Journal of Drug Issues, 30(3), 555–574.
Brewer, J. A., & Potenza, M. N. (2008). The neurobiology and genetics of impulse control disorders: relationships to drug addictions. Biochemical Pharmacology, 75(1), 63–75.
Bühringer, G., Kräplin, A., & Behrendt, S. (2012). Universal characteristics and consequences of the addiction syndrome. In H. J. Shaffer (Ed.), APA addiction syndrome handbook (pp. 291–316). Washington: American Psychological Association.
Casavant, L. & Collin, C. (2001). Illegal drug use and crime: a complex relationship Political and Social Affairs Division. Retrieved at http://www.parl.gc.ca/content/sen/committee/371/ille/library/collin-e.htm#_ftn1
Cavedini, P., Riboldi, G., Keller, R., D’Annucci, A., & Bellodi, L. (2002). Frontal lobe dysfunction in pathological gambling patients. Biological Psychiatry, 51(4), 334–341.
Chandler, R. K., Fletcher, B. W., & Volkow, N. D. (2009). Treating drug abuse and addiction in the criminal justice system: Improving public health and safety. The Journal of the American Medical Association, 301(2), 183–190.
Darke, S., Williamson, A., Ross, J., Mills, K. L., Havard, A., & Teesson, M. (2007). Patterns of nonfatal heroin overdose over a 3-year period: findings from the Australian treatment outcome study. Journal of Urban Health, 84(2), 283–291.
Dodge, R., Sindelar, J., & Sinha, R. (2005). The role of depressive symptoms in predicting drug abstinence in outpatient substance abuse treatment. Journal of Substance Abuse Treatment, 28, 189–196.
Edenberg, H. J., & Foroud, T. (2006). Review: the genetics of alcoholism: identifying specific genes through family studies. Addiction Biology, 11(3–4), 386–396.
Enoch, M. A. (2011). The role of early life stress as a predictor for alcohol and drug dependence. Psychopharmacology, 214, 17–31.
Ersche, K. D., Turton, A. J., Pradhan, S., Bullmore, E. T., & Robbins, T. W. (2010). Drug addiction endophenotypes: impulsive versus sensation-seeking personality traits. Biological Psychiatry, 68(8), 770–773.
Evans, J. L., Hahn, J. A., Lum, P. J., Stein, E. S., & Page, K. (2009). Predictors of injection drug use cessation and relapse in a prospective cohort of young injection drug users in San Francisco, CA (UFO Study). Drug and Alcohol Dependence, 101(3), 152–157. doi:10.1016/j.drugalcdep.2008.12.007.
Eysenck, H. J. (1997). Addiction, personality and motivation. Human Psychopharmacology: Clinical and Experimental, 12(S2), S79–S87.
Fulcher, G. M. (2009). Motherhood and motivation for substance abuse treatment and behavior change. Berkeley, ProQuest, Los Angeles: University of California.
Galvan, A., Hare, T., Parra, C., Penn, J., Voss, H., Glover, G., & Casey, B. J. (2006). Earlier development of the accumbens relative to orbitofrontal cortex might underlie risk-taking behavior in adolescents. Journal of Neuroscience, 26(25), 6885–6892. doi:10.1523/JNEUROSCI.1062-06.2006.
Gluckman, P., Low, F. Franko K. et al. (2011). Improving the transition: reducing social and psychological morbidity during adolescence. A report from the Prime Minister’s Chief Science Advisor. Office of the Prime Minister’s Science Advisory Committee, New Zealand.
Gossop, M., Stewart, D., Browne, N., & Marsden, J. (2002). Factors associated with abstinence, lapse or relapse to heroin use after residential treatment: protective effect of coping responses. Addiction, 97, 1259–1267.
Grace, A. A. (2000). The tonic/phasic model of dopamine system regulation and its implications for understanding alcohol and psychostimulant craving. Addiction, 95, S119–S128.
Grant, J. E., Potenza, M. N., Weinstein, A., & Gorelick, D. A. (2010). Introduction tobehavioral addictions. The American Journal of Drug and Alcohol Abuse, 36(5), 233–241.
Gyollai, Á. D., Griffiths, M., Barta, C., Vereczkei, A., Urbán, R., Kun, B., & Demetrovics, Z. (2014). The genetics of problem and pathological gambling: a systematic review. Current Pharmaceutical Design, 20(25), 3993–3999.
Heinz, A. J., Wu, J., Witkiewitz, K., Epstein, D. H., & Preston, K. L. (2009). Marriage and relationship closeness as predictors of cocaine and heroin use. Addictive Behaviors, 34(3), 258–263. doi:10.1016/j.addbeh.2008.10.020.
Henkel, L.J., (2007). Substance abuse severity, treatment motivation, and criminal thinking factors: predictors of treatment retention with substance abusing parolees in a correctional aftercare program (Psychology Dissertations). Philadelphia College of Osteopathic Medicine, paper 61.
Hser, Y. I. (2007). Predicting long-term stable recovery from heroin addiction: Findings from a 33-year follow-up study. Journal of Addiction Disorders, 26(1), 51–60.
Ibáñez, A., Blanco, C., de Castro, I. P., Fernandez-Piqueras, J., & Sáiz-Ruiz, J. (2003). Genetics of pathological gambling. Journal of Gambling Studies, 19(1), 11–22.
James, L. (2012). Understanding the process of recovery from heroin addiction: initiating and maintaining factors (Unpublished doctoral dissertation). Cardiff University and the South Wales.
Knežević-Tasić, J., & Đukanović, B. (2015). Bihevioralne zavisnosti u Srbiji. Beograd: Izdavačka knjižarnica Zorana Stojanovića.
Koob, G. F., & Volkow, N. D. (2010). Neurocircuitry of addiction. Neuropsychopharmacology, 35(1), 217–238. doi:10.1038/npp.2009.110.
Koob, G. F., Ahmed, S. H., Boutrel, B., et al. (2004). Neurobiological mechanisms in the transition from drug use to drug dependence. Neuroscience Biobehavior Review, 27, 739–749.
Kosten, T. A., Ball, S. A., & Rounsaville, B. J. (1994). A sibling study of sensation seeking and opiate addiction. Journal of Nervous and Mental Disease, 182(5), 284–289.
Krupitsky, E., Zvartau, E., Masalov, D., Tsoi, M., Burakov, A., Egorova, V., Didenko, T., Romanova, T., Ivanova, E., Bespalov, A., Verbitskaya, E., Neznanov, N., Grinenko, A., O'Brien, C., & Woody, G. (2004). Naltrexone for heroin dependence treatment in St. Petersburg, Russia. Journal of Substance Abuse Treatment, 26(4), 285–294.
Lin, S. S., & Tsai, C. C. (2002). Sensation seeking and internet dependence of Taiwanese high school adolescents. Computers in Human Behavior, 18(4), 411–426.
Lobo, D. S., & Kennedy, J. L. (2006). The genetics of gambling and behavioural addictions. CNS Spectrums, 11(12), 931–939.
McKay, J. R., Rutherford, M. J., Alterman, A. I., et al. (1995). An examination of the cocaine relapse process. Drug Alcohol Dependance, 38, 35–43.
Miller, W. R., & Rollnick, S. (2012). Motivational interviewing: helping people change. Guilford press.
National Institute on Drug Abuse (2010). Comorbidity: addiction and other mental illnesses–in-depth report on co-occurring drug use and other mental disorders. Retrieved at https://www.drugabuse.gov/sites/default/files/rrcomorbidity.pdf
Pavlović, Z., & Jakovljević, B. (2008). Učestalost i faktori rizika od upotrebe psihoaktivnih supstancija kod mladih. Vojnosanitetski Pregled, 65(6), 441–448.
Prochaska, J. O., & DiClemente, C. C. (1984). The transtheoretic approach: crossing traditional boundaries of therapy. Homewood, Illinois: Dow Jones/Irwin.
Prochaska, J. O., & DiClemente, C. C. (1992). The trans-theoretical approach. In J. C. Norcross & M. R. Goldfried (Eds.), Handbook of psychotherapy integration (pp. 330–334). New York: Basic Books, Inc..
Rapp, R. C., Siegel, H. A., & DeLiberty, R. N. (2003). Demographic and clinical correlates of client motivation among substance abusers. Health & Social Work, 28(2), 107–115.
Schmitz, J., Stotts, A., Rhoades, H., & Grabowski, J. (2001). Naltrexone and relapse prevention treatment for cocaine-dependent patients. Addictive Behaviors., 26(2), 167–180.
Schuckit, M. A. (2009). An overview of genetic influences in alcoholism. Journal of Substance Abuse Treatment, 36(1), 5–14.
Shaffer, H. (2012). APA Addiction Syndrome Handbook: Foundations, Influences, and Expressions of Addiction, Vol 1. Washington, DC: American Psychological Association.
Shaffer, H. J., LaPlante, D. A., LaBrie, R. A., Kidman, R. C., Donato, A. N., & Stanton, M. V. (2004). Toward a syndrome model of addiction: multiple expressions, common etiology. Harvard Review Psychiatry, 12(6), 367–374.
Sinha, R. (2001). How does stress increase risk of drug abuse and relapse? Psychopharmacology, 158, 343–359.
Sinha, R. (2008). Chronic stress, drug use, and vulnerability to addiction. Annals of the New York Academy of Sciences, 1141, 105–130. doi:10.1196/annals.1441.030.
Sinha, R. (2011). New findings on biological factors predicting addiction relapse vulnerability. Current Psychiatry Reports, 13(5), 398–405. doi:10.1007/s11920-011-0224-0.
Tsogia, D., Capello, A., & Orford, J. (2001). Entering treatment for substance misuse: a review of the literature. Journal of Mental Health, 10(5), 481–499.
Ubale, V. M., Jaju, J. B., Gosavi, P. A., Pawar, G. R., Dharmadhikari, S. C., & Parekar, S. M. (2015). Evaluation of antidepressant activity of tramadol in mice: an experimental study. International Journal of Basic & Clinical Pharmacology, 4(3), 463–468. doi:10.18203/2319-2003.ijbcp20150017.
United Nations Office on Drugs and Crime (2013). Opioid overdose: preventing and reducing opioid overdose mortality. United Nations Office at Vienna. Retrieved at https://www.unodc.org/docs/treatment/overdose.pdf. Accessed 27 Oct 2015.
United Nations Office on Drugs and Crime (2015). World drug report 2015. United Nations Office at Vienna.
United Nations Office for Drug and Crime (2016). UNODC-WHO The International Standards for the Treatment of Drug Use Disorders. Retrieved at https://www.unodc.org/unodc/en/drug-prevention-and-treatment/publications.html
UNODC, Addiction, Crime and Insurgency (2009). Heroin. Retrieved at https://www.unodc.org/documents/data-and-analysis/tocta/5.Heroin.pdf
Volkow, N. D., Wang, G. J., Fowler, J. S., Franceschi, D., Thanos, P. K., Wong, C., et al. (2000). Cocaine abusers show a blunted response to alcohol intoxication in limbic brain regions. Life Science, 66, PL161–PL167.
Zule, P., Lam, W. K. K., & Wechsberg, W. M. (2003). Treatment readiness among out-of-treatment African-American crack users. Journal of Psychoactive Drugs, 35(4), 502–510.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Contributors
All authors were involved in the study design, had full access to the survey data and analyses, and interpreted the data, critically reviewed the manuscript and had full control, including final responsibility for the decision to submit the paper for publication.
Conflict of Interest
The authors declare that they have no competing interests.
Informed Consent and Ethics
Authors confirm that the submitted study was conducted according to the WMA Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects. This study has ethics committee approval. All patients gave their informed consent to the anonymous use of their clinical data for this independent study.
Rights and permissions
About this article
Cite this article
Tasić, J.K., Valkanou, M.K., Đukanović, B. et al. Relapse Risk Factors in Heroin Addicts Treated with Naltrexone and Naltrexone-Behavioural Psychotherapy. Int J Ment Health Addiction 16, 351–365 (2018). https://doi.org/10.1007/s11469-017-9782-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11469-017-9782-7